• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香草醛通过抗炎和抗氧化途径防止子宫内膜异位症病变在小鼠模型中的生长。

Vanillin prevents the growth of endometriotic lesions through anti-inflammatory and antioxidant pathways in a mouse model.

机构信息

College of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, China.

出版信息

Food Funct. 2023 Jul 17;14(14):6730-6744. doi: 10.1039/d3fo00750b.

DOI:10.1039/d3fo00750b
PMID:37409688
Abstract

Endometriosis is an estrogen-dependent chronic inflammatory gynecological disease defined by the presence of endometrial glands and mesenchyme outside the uterine cavity, named ectopic endometrium. Recent studies showed that endometriosis is associated with hormone imbalance, inflammation and oxidative stress. As the main component of vanilla bean extract, vanillin is widely used as a flavoring agent in the food, pharmaceutical, and cosmetic industries. It is known for its anti-inflammatory, antibacterial, and antitumor properties, but its therapeutic efficacy in endometriosis has not been studied. In this study, we evaluated the roles of vanillin in this disease using an induced endometriotic mouse model. The results showed that vanillin significantly inhibited the growth of endometrial lesions. Compared with the control group, the weight and volume of lesions were reduced considerably in the vanillin-treated group, showing its fantastic ability to inhibit cell proliferation and promote apoptosis. In addition, in the treatment group, mRNA expression of the pro-inflammatory cytokines , , , and was reduced, the number of macrophages and neutrophils was decreased, and the NF-κB signaling pathway was inhibited, indicating that vanillin suppressed the inflammatory response in the ectopic endometrium. Besides, we found that the intensity of tissue reactive oxygen species (ROS) was significantly lower, and mitochondrial complex IV expression was reduced in the vanillin-treated group. Meanwhile, treatment of the immortalized human endometriotic epithelial cell line (11Z) with vanillin resulted in the downregulation of cyclin genes that drive the cell proliferation process, inhibited cell proliferation, promoted apoptosis, and downregulated the expression of LPS-induced inflammatory cytokines. Most importantly, our data showed that the vanillin treatment had only minimal effects on the eutopic endometrium with respect to the pregnancy process, indicating its safety to be used in treating endometriosis in adults. In conclusion, our data suggest that vanillin has potential therapeutic properties for endometriosis as a regulatory molecule of cell proliferation, apoptosis, inflammation, and oxidative stress.

摘要

子宫内膜异位症是一种雌激素依赖性的慢性炎症性妇科疾病,其特征是子宫内膜腺体和基质位于子宫腔外,被称为异位内膜。最近的研究表明,子宫内膜异位症与激素失衡、炎症和氧化应激有关。香草醛是香草豆提取物的主要成分,作为一种调味剂广泛应用于食品、制药和化妆品行业。它具有抗炎、抗菌和抗肿瘤特性,但尚未研究其在子宫内膜异位症中的治疗效果。在这项研究中,我们使用诱导子宫内膜异位症的小鼠模型评估了香草醛在这种疾病中的作用。结果表明,香草醛显著抑制子宫内膜病变的生长。与对照组相比,香草醛治疗组的病变重量和体积明显减小,表明其抑制细胞增殖和促进细胞凋亡的能力很强。此外,在治疗组中,促炎细胞因子 、 、 、 的 mRNA 表达减少,巨噬细胞和中性粒细胞数量减少,NF-κB 信号通路受到抑制,表明香草醛抑制了异位内膜的炎症反应。此外,我们发现香草醛治疗组组织活性氧(ROS)的强度明显降低,线粒体复合物 IV 的表达减少。同时,香草醛处理永生化人子宫内膜异位上皮细胞系(11Z)导致驱动细胞增殖过程的细胞周期基因下调,抑制细胞增殖,促进细胞凋亡,并下调 LPS 诱导的炎症细胞因子的表达。最重要的是,我们的数据表明,香草醛治疗对妊娠过程中的在位子宫内膜只有很小的影响,表明其在治疗成人子宫内膜异位症方面具有安全性。总之,我们的数据表明,香草醛作为细胞增殖、凋亡、炎症和氧化应激的调节分子,具有治疗子宫内膜异位症的潜力。

相似文献

1
Vanillin prevents the growth of endometriotic lesions through anti-inflammatory and antioxidant pathways in a mouse model.香草醛通过抗炎和抗氧化途径防止子宫内膜异位症病变在小鼠模型中的生长。
Food Funct. 2023 Jul 17;14(14):6730-6744. doi: 10.1039/d3fo00750b.
2
Zearalenone affects the growth of endometriosis via estrogen signaling and inflammatory pathways.玉米赤霉烯酮通过雌激素信号传导和炎症途径影响子宫内膜异位症的生长。
Ecotoxicol Environ Saf. 2022 Aug;241:113826. doi: 10.1016/j.ecoenv.2022.113826. Epub 2022 Jun 30.
3
The ellagic acid metabolites urolithin A and B differentially affect growth, adhesion, motility, and invasion of endometriotic cells in vitro.鞣花酸代谢物尿石素 A 和 B 可体外差异影响子宫内膜异位细胞的生长、黏附、迁移和侵袭。
Hum Reprod. 2021 May 17;36(6):1501-1519. doi: 10.1093/humrep/deab053.
4
Silibinin-induced endoplasmic reticulum stress and mitochondrial dysfunction suppress growth of endometriotic lesions.水飞蓟宾诱导的内质网应激和线粒体功能障碍抑制子宫内膜异位症病灶的生长。
J Cell Physiol. 2019 Apr;234(4):4327-4341. doi: 10.1002/jcp.27212. Epub 2018 Aug 25.
5
Enhanced expression of TACE contributes to elevated levels of sVCAM-1 in endometriosis.TACE 的表达增强导致子宫内膜异位症中 sVCAM-1 水平升高。
Mol Hum Reprod. 2019 Feb 1;25(2):76-87. doi: 10.1093/molehr/gay042.
6
Synthetic flavokawain analog (E)-1-(2'-hydroxy-4',6'-dimethoxyphenyl)-3-(3-methoxy-4-(3-morpholinopropoxy)phenyl)prop-2-en-1-one (FK-morph) effectively regresses endometriotic implants in rats.合成 flavokawain 类似物 (E)-1-(2'-羟基-4',6'-二甲氧基苯基)-3-(3-甲氧基-4-(3-吗啉代丙氧基)苯基)丙-2-烯-1-酮 (FK-morph) 可有效使大鼠子宫内膜异位症病灶消退。
Eur J Pharmacol. 2022 Oct 15;933:175240. doi: 10.1016/j.ejphar.2022.175240. Epub 2022 Aug 31.
7
T-cadherin inhibits invasion and migration of endometrial stromal cells in endometriosis.T 钙黏蛋白抑制子宫内膜异位症中子宫内膜基质细胞的侵袭和迁移。
Hum Reprod. 2020 Jan 1;35(1):145-156. doi: 10.1093/humrep/dez252.
8
IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression.白细胞介素-10在子宫内膜异位症中并非抗纤维化而是促纤维化:体外对子宫内膜异位症基质细胞进行白细胞介素-10处理可促进肌成纤维细胞增殖及I型胶原蛋白表达。
Hum Reprod. 2023 Jan 5;38(1):14-29. doi: 10.1093/humrep/deac248.
9
Inhibitor of apoptosis proteins (IAPs) may be effective therapeutic targets for treating endometriosis.凋亡抑制蛋白(IAPs)可能是治疗子宫内膜异位症的有效治疗靶点。
Hum Reprod. 2015 Jan;30(1):149-58. doi: 10.1093/humrep/deu288. Epub 2014 Nov 5.
10
Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology.雌激素介导肥大细胞在子宫内膜异位症病理生理学中的炎症作用。
Front Immunol. 2022 Aug 9;13:961599. doi: 10.3389/fimmu.2022.961599. eCollection 2022.

引用本文的文献

1
Endometriosis and autoimmunity.子宫内膜异位症与自身免疫
Autoimmun Rev. 2025 Mar 26;24(4):103752. doi: 10.1016/j.autrev.2025.103752. Epub 2025 Jan 17.
2
Unlocking the Potential: How Flavonoids Affect Angiogenesis, Oxidative Stress, Inflammation, Proliferation, Invasion, and Alter Receptor Interactions in Endometriosis.释放潜能:黄酮类化合物如何影响子宫内膜异位症中的血管生成、氧化应激、炎症、增殖、侵袭及改变受体相互作用
Food Sci Nutr. 2024 Dec 7;13(1):e4607. doi: 10.1002/fsn3.4607. eCollection 2025 Jan.
3
Vanillin Has Potent Antibacterial, Antioxidant, and Anti-Inflammatory Activities In Vitro and in Mouse Colitis Induced by Multidrug-Resistant .
香草醛在体外以及由多重耐药菌诱导的小鼠结肠炎模型中具有强大的抗菌、抗氧化和抗炎活性。
Antioxidants (Basel). 2024 Dec 17;13(12):1544. doi: 10.3390/antiox13121544.
4
Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses.百里香酚通过破坏雌激素信号通路和炎症反应影响子宫内膜异位症的进展。
Int J Mol Sci. 2024 Dec 7;25(23):13150. doi: 10.3390/ijms252313150.
5
Systemic inflammatory indices as a non-invasive grading modality for endometriosis: a comparative study versus exploratory laparoscopy.全身炎症指标作为子宫内膜异位症的一种非侵入性分级方式:与 exploratory laparoscopy 的对比研究 。(注:“exploratory laparoscopy”直译为“探索性腹腔镜检查”,可能是一种特定的腹腔镜检查类型,这里按原文保留未翻译)
Rev Bras Ginecol Obstet. 2024 Dec 4;46. doi: 10.61622/rbgo/2024rbgo84. eCollection 2024.
6
An Overview of Bioactive Compounds' Role in Modulating the Nrf2/Keap1/NF-κB Pathway to Alleviate Lipopolysaccharide-Induced Endometritis.生物活性化合物在调节 Nrf2/Keap1/NF-κB 通路减轻脂多糖诱导的子宫内膜炎中的作用概述。
Int J Mol Sci. 2024 Sep 25;25(19):10319. doi: 10.3390/ijms251910319.
7
Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.基于血清药物化学和网络药理学的洛氏内异方治疗子宫内膜异位症的潜在机制
Front Pharmacol. 2024 Jul 29;15:1395160. doi: 10.3389/fphar.2024.1395160. eCollection 2024.
8
Vanillin Promotes Osteoblast Differentiation, Mineral Apposition, and Antioxidant Effects in Pre-Osteoblasts.香草醛促进前成骨细胞的成骨细胞分化、矿物质沉积及抗氧化作用。
Pharmaceutics. 2024 Apr 1;16(4):485. doi: 10.3390/pharmaceutics16040485.